Merck, Pfizer, Syndax Collaborate to evaluate combination drug for ovarian cancer
Dr. Luciano Rossetti
Head, Global Research & Development, Merck biopharma business
Multinational pharmaceutical companies, Merck, Pfizer and Syndax Pharmaceuticals, Inc. have entered into a collaboration agreement to evaluate…